An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers
Adenosine triphosphate (ATP)-activated prodrug approaches demonstrate potential in antibacterial uses. However, their efficacy frequently faces obstacles due to uncontrolled premature activation and spatiotemporal distribution differences under physiological circumstances. Herein, we present an endo...
Saved in:
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
KeAi Communications Co., Ltd.
2025-03-01
|
Series: | Bioactive Materials |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2452199X24005206 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832586261799370752 |
---|---|
author | Xiaoliang Qi Yajing Xiang Ying Li Jiajia Wang Yuxi Chen Yulong Lan Jinsong Liu Jianliang Shen |
author_facet | Xiaoliang Qi Yajing Xiang Ying Li Jiajia Wang Yuxi Chen Yulong Lan Jinsong Liu Jianliang Shen |
author_sort | Xiaoliang Qi |
collection | DOAJ |
description | Adenosine triphosphate (ATP)-activated prodrug approaches demonstrate potential in antibacterial uses. However, their efficacy frequently faces obstacles due to uncontrolled premature activation and spatiotemporal distribution differences under physiological circumstances. Herein, we present an endogenous ATP-activated prodrug system (termed ISD3) consisting of nanoparticles (indole-3-acetic acid/zeolitic imidazolate framework-8@polydopamine@platinum, IZPP) embedded in a silk fibroin-based hydrogel, aimed at treating multidrug-resistant (MDR) bacteria-infected pressure ulcers. Initially, an ultraviolet-triggered adhesive ISD3 barrier is formed over the pressure ulcer wound by a simple local injection. Subsequently, the bacteria-secreted ATP prompts the degradation of IZPP, allowing the loaded IAA prodrug and nanozyme to encounter spatiotemporally on a single carrier, thereby efficiently generating reactive oxygen species (ROS). Exposure to 808 nm near-infrared light enhances the catalytic reaction speed, boosting ROS levels for stronger antibacterial action. Once optimal antibacterial action is reached, ISD3 switches to a dormant state, halting any further ROS production. Moreover, the bioactive components in ISD3 can exert anti-inflammatory functions, aiding in pressure ulcer recovery. Overall, our research introduces a hydrogel prodrug strategy activated by bacterial endogenous ATP, which precisely manages ROS generation and accelerates the recovery of MDR bacteria-infected pressure ulcers. |
format | Article |
id | doaj-art-5afc99cb45c44bd39585ea64182fd170 |
institution | Kabale University |
issn | 2452-199X |
language | English |
publishDate | 2025-03-01 |
publisher | KeAi Communications Co., Ltd. |
record_format | Article |
series | Bioactive Materials |
spelling | doaj-art-5afc99cb45c44bd39585ea64182fd1702025-01-26T05:04:25ZengKeAi Communications Co., Ltd.Bioactive Materials2452-199X2025-03-0145301321An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcersXiaoliang Qi0Yajing Xiang1Ying Li2Jiajia Wang3Yuxi Chen4Yulong Lan5Jinsong Liu6Jianliang Shen7National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, ChinaSchool & Hospital of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, ChinaZhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325001, ChinaZhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325001, ChinaSchool & Hospital of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, ChinaZhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325001, ChinaSchool & Hospital of Stomatology, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, ChinaNational Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China; Zhejiang Engineering Research Center for Tissue Repair Materials, Wenzhou Institute, University of Chinese Academy of Sciences, Wenzhou, Zhejiang, 325001, China; Corresponding author. National Engineering Research Center of Ophthalmology and Optometry, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.Adenosine triphosphate (ATP)-activated prodrug approaches demonstrate potential in antibacterial uses. However, their efficacy frequently faces obstacles due to uncontrolled premature activation and spatiotemporal distribution differences under physiological circumstances. Herein, we present an endogenous ATP-activated prodrug system (termed ISD3) consisting of nanoparticles (indole-3-acetic acid/zeolitic imidazolate framework-8@polydopamine@platinum, IZPP) embedded in a silk fibroin-based hydrogel, aimed at treating multidrug-resistant (MDR) bacteria-infected pressure ulcers. Initially, an ultraviolet-triggered adhesive ISD3 barrier is formed over the pressure ulcer wound by a simple local injection. Subsequently, the bacteria-secreted ATP prompts the degradation of IZPP, allowing the loaded IAA prodrug and nanozyme to encounter spatiotemporally on a single carrier, thereby efficiently generating reactive oxygen species (ROS). Exposure to 808 nm near-infrared light enhances the catalytic reaction speed, boosting ROS levels for stronger antibacterial action. Once optimal antibacterial action is reached, ISD3 switches to a dormant state, halting any further ROS production. Moreover, the bioactive components in ISD3 can exert anti-inflammatory functions, aiding in pressure ulcer recovery. Overall, our research introduces a hydrogel prodrug strategy activated by bacterial endogenous ATP, which precisely manages ROS generation and accelerates the recovery of MDR bacteria-infected pressure ulcers.http://www.sciencedirect.com/science/article/pii/S2452199X24005206Prodrug systemsAdenosine triphosphate responseHydrogelsMultidrug-resistant bacterial infectionPressure ulcers |
spellingShingle | Xiaoliang Qi Yajing Xiang Ying Li Jiajia Wang Yuxi Chen Yulong Lan Jinsong Liu Jianliang Shen An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers Bioactive Materials Prodrug systems Adenosine triphosphate response Hydrogels Multidrug-resistant bacterial infection Pressure ulcers |
title | An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers |
title_full | An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers |
title_fullStr | An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers |
title_full_unstemmed | An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers |
title_short | An ATP-activated spatiotemporally controlled hydrogel prodrug system for treating multidrug-resistant bacteria-infected pressure ulcers |
title_sort | atp activated spatiotemporally controlled hydrogel prodrug system for treating multidrug resistant bacteria infected pressure ulcers |
topic | Prodrug systems Adenosine triphosphate response Hydrogels Multidrug-resistant bacterial infection Pressure ulcers |
url | http://www.sciencedirect.com/science/article/pii/S2452199X24005206 |
work_keys_str_mv | AT xiaoliangqi anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT yajingxiang anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT yingli anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT jiajiawang anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT yuxichen anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT yulonglan anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT jinsongliu anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT jianliangshen anatpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT xiaoliangqi atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT yajingxiang atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT yingli atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT jiajiawang atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT yuxichen atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT yulonglan atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT jinsongliu atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers AT jianliangshen atpactivatedspatiotemporallycontrolledhydrogelprodrugsystemfortreatingmultidrugresistantbacteriainfectedpressureulcers |